TABLE 2.
Cethromycin and telithromycin MICs displayed according to macrolide, lincosamide, and streptogramin susceptibility
| Phenotype and druga | No. of isolates for which the ketolide MIC (μg/ml) was:
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.015 | 0.03 | 0.06 | 0.12 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | |
| Erys and Clis | |||||||||||
| Cethromycin | 68 | ||||||||||
| Telithromycin | 67 | 1 | |||||||||
| Eryr and Clis (M phenotype) | |||||||||||
| Cethromycin | 12 | 9 | 9 | 12 | 1 | ||||||
| Telithromycin | 11 | 12 | 18 | ||||||||
| Eryr and Clir (MLSB phenotype) | |||||||||||
| Cethromycin | 27 | 9 | 1 | 1 | 1 | 6 | |||||
| Telithromycin | 9 | 23 | 5 | 6 | 2 | 1 | |||||
| Q-Dr | |||||||||||
| Cethromycin | 1 | 3 | 1 | 1 | |||||||
| Telithromycin | 4 | 1 | 1 | ||||||||
a
Ery, erythromycin; Cli, clindamycin; Q-D, quinupristin-dalfopristin.